BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 29067538)

  • 1. Inhibitors of apoptosis: clinical implications in cancer.
    Mohamed MS; Bishr MK; Almutairi FM; Ali AG
    Apoptosis; 2017 Dec; 22(12):1487-1509. PubMed ID: 29067538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting inhibitor of apoptosis proteins for therapeutic intervention.
    Ndubaku C; Cohen F; Varfolomeev E; Vucic D
    Future Med Chem; 2009 Nov; 1(8):1509-25. PubMed ID: 21426063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of small-molecule Smac mimetics as IAP antagonists.
    Wang S
    Curr Top Microbiol Immunol; 2011; 348():89-113. PubMed ID: 21072626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploiting inhibitor of apoptosis proteins as therapeutic targets in hematological malignancies.
    Fulda S
    Leukemia; 2012 Jun; 26(6):1155-65. PubMed ID: 22230799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibitors of apoptosis (IAPs) as cancer targets.
    Hunter AM; LaCasse EC; Korneluk RG
    Apoptosis; 2007 Sep; 12(9):1543-68. PubMed ID: 17573556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting IAP proteins for therapeutic intervention in cancer.
    Fulda S; Vucic D
    Nat Rev Drug Discov; 2012 Feb; 11(2):109-24. PubMed ID: 22293567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathways: targeting death receptors and smac mimetics.
    Fulda S
    Clin Cancer Res; 2014 Aug; 20(15):3915-20. PubMed ID: 24824309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting the inhibitors: Targeting anti-apoptotic proteins in cancer and therapy resistance.
    Shahar N; Larisch S
    Drug Resist Updat; 2020 Sep; 52():100712. PubMed ID: 32599435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting IAP (inhibitor of apoptosis) proteins for therapeutic intervention in tumors.
    Vucic D
    Curr Cancer Drug Targets; 2008 Mar; 8(2):110-7. PubMed ID: 18336193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The IAP Protein Family, SMAC Mimetics and Cancer Treatment.
    Philchenkov A; Miura K
    Crit Rev Oncog; 2016; 21(3-4):185-202. PubMed ID: 27915971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Livin/melanoma inhibitor of apoptosis protein as a potential therapeutic target for the treatment of malignancy.
    Chang H; Schimmer AD
    Mol Cancer Ther; 2007 Jan; 6(1):24-30. PubMed ID: 17237263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IAP Proteins Antagonist: An Introduction and Chemistry of Smac Mimetics under Clinical Development.
    Ali R; Singh S; Haq W
    Curr Med Chem; 2018; 25(31):3768-3795. PubMed ID: 29532750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked.
    Hannes S; Abhari BA; Fulda S
    Cancer Lett; 2016 Sep; 380(1):31-8. PubMed ID: 27267809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IAP antagonists: promising candidates for cancer therapy.
    Mannhold R; Fulda S; Carosati E
    Drug Discov Today; 2010 Mar; 15(5-6):210-9. PubMed ID: 20096368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting endogenous inhibitors of apoptosis for treatment of cancer, stroke and multiple sclerosis.
    HolcĂ­k M
    Expert Opin Ther Targets; 2004 Jun; 8(3):241-53. PubMed ID: 15161430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smac mimetics as IAP antagonists.
    Fulda S
    Semin Cell Dev Biol; 2015 Mar; 39():132-8. PubMed ID: 25550219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advances in studies on inhibitor of apoptosis proteins and cancer therapy].
    Wang XH; Fu LW
    Yao Xue Xue Bao; 2006 Feb; 41(2):103-7. PubMed ID: 16671537
    [No Abstract]   [Full Text] [Related]  

  • 18. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.
    Zobel K; Wang L; Varfolomeev E; Franklin MC; Elliott LO; Wallweber HJ; Okawa DC; Flygare JA; Vucic D; Fairbrother WJ; Deshayes K
    ACS Chem Biol; 2006 Sep; 1(8):525-33. PubMed ID: 17168540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function.
    Wright CW; Duckett CS
    J Clin Invest; 2005 Oct; 115(10):2673-8. PubMed ID: 16200201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitor of apoptosis proteins as targets for anticancer therapy.
    Fulda S
    Expert Rev Anticancer Ther; 2007 Sep; 7(9):1255-64. PubMed ID: 17892425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.